Cargando…
The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model
BACKGROUND: P19 H-Ras, a second product derived from the H-Ras gene by alternative splicing, induces a G1/S phase delay, thereby maintaining cells in a reversible quiescence state. When P21 H-Ras is mutated in tumour cells, the alternative protein P19 H-Ras is also mutated. The H-Ras mutation Q61L i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631104/ https://www.ncbi.nlm.nih.gov/pubmed/26138095 http://dx.doi.org/10.1186/s12881-015-0184-z |
_version_ | 1782398815234424832 |
---|---|
author | García-Cruz, Roseli Camats, Maria Calin, George A. Liu, Chang-Gong Volinia, Stefano Taccioli, Cristian Croce, Carlo M. Bach-Elias, Montse |
author_facet | García-Cruz, Roseli Camats, Maria Calin, George A. Liu, Chang-Gong Volinia, Stefano Taccioli, Cristian Croce, Carlo M. Bach-Elias, Montse |
author_sort | García-Cruz, Roseli |
collection | PubMed |
description | BACKGROUND: P19 H-Ras, a second product derived from the H-Ras gene by alternative splicing, induces a G1/S phase delay, thereby maintaining cells in a reversible quiescence state. When P21 H-Ras is mutated in tumour cells, the alternative protein P19 H-Ras is also mutated. The H-Ras mutation Q61L is frequently detected in different tumours, which acts as constitutive activator of Ras functions and is considered to be a strong activating mutant. Additionally, a rare congenital disorder named Costello Syndrome, is described as a H-Ras disorder in children, mainly due to mutation G12S in p19 and p21 H-Ras proteins, which is present in 90 % of the Costello Syndrome patients. Our aim is to better understand the role of p19 and p21 H-Ras proteins in the cancer and Costello Syndrome development, concerning the miRNAs expression. METHODS: Total miRNAs expression regulated by H-Ras proteins were first analyzed in human miRNA microarrays assays. Previously selected miRNAs, were further analyzed in developed cell lines containing H-Ras protein mutants, that included the G12S Costello Syndrome mutant, with PCR Real-Time Taq Man miRNA Assays primers. RESULTS: This study describes how p19 affects the RNA world and shows that: i) miR-342, miR-206, miR-330, miR-138 and miR-99b are upregulated by p19 but not by p19W164A mutant; ii) anti-miR-206 can restore the G2 phase in the presence of p19; iii) p19 and p21Q61L regulate their own alternative splicing; iv) miR-206 and miR-138 are differentially regulated by p19 and p21 H-Ras and v) P19G12S Costello mutants show a clear upregulation of miR-374, miR-126, miR-342, miR-330, miR-335 and let-7. CONCLUSIONS: These results allow us to conclude that the H-Ras G12S mutation plays an important role in miRNA expression and open up a new line of study to understand the consequences of this mutation on Costello syndrome. Furthermore, they suggest that oncogenes may have a sufficiently important impact on miRNA expression to promote the development of numerous cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-015-0184-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4631104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46311042015-11-04 The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model García-Cruz, Roseli Camats, Maria Calin, George A. Liu, Chang-Gong Volinia, Stefano Taccioli, Cristian Croce, Carlo M. Bach-Elias, Montse BMC Med Genet Research Article BACKGROUND: P19 H-Ras, a second product derived from the H-Ras gene by alternative splicing, induces a G1/S phase delay, thereby maintaining cells in a reversible quiescence state. When P21 H-Ras is mutated in tumour cells, the alternative protein P19 H-Ras is also mutated. The H-Ras mutation Q61L is frequently detected in different tumours, which acts as constitutive activator of Ras functions and is considered to be a strong activating mutant. Additionally, a rare congenital disorder named Costello Syndrome, is described as a H-Ras disorder in children, mainly due to mutation G12S in p19 and p21 H-Ras proteins, which is present in 90 % of the Costello Syndrome patients. Our aim is to better understand the role of p19 and p21 H-Ras proteins in the cancer and Costello Syndrome development, concerning the miRNAs expression. METHODS: Total miRNAs expression regulated by H-Ras proteins were first analyzed in human miRNA microarrays assays. Previously selected miRNAs, were further analyzed in developed cell lines containing H-Ras protein mutants, that included the G12S Costello Syndrome mutant, with PCR Real-Time Taq Man miRNA Assays primers. RESULTS: This study describes how p19 affects the RNA world and shows that: i) miR-342, miR-206, miR-330, miR-138 and miR-99b are upregulated by p19 but not by p19W164A mutant; ii) anti-miR-206 can restore the G2 phase in the presence of p19; iii) p19 and p21Q61L regulate their own alternative splicing; iv) miR-206 and miR-138 are differentially regulated by p19 and p21 H-Ras and v) P19G12S Costello mutants show a clear upregulation of miR-374, miR-126, miR-342, miR-330, miR-335 and let-7. CONCLUSIONS: These results allow us to conclude that the H-Ras G12S mutation plays an important role in miRNA expression and open up a new line of study to understand the consequences of this mutation on Costello syndrome. Furthermore, they suggest that oncogenes may have a sufficiently important impact on miRNA expression to promote the development of numerous cancers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12881-015-0184-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-07-03 /pmc/articles/PMC4631104/ /pubmed/26138095 http://dx.doi.org/10.1186/s12881-015-0184-z Text en © García-Cruz et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article García-Cruz, Roseli Camats, Maria Calin, George A. Liu, Chang-Gong Volinia, Stefano Taccioli, Cristian Croce, Carlo M. Bach-Elias, Montse The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model |
title | The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model |
title_full | The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model |
title_fullStr | The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model |
title_full_unstemmed | The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model |
title_short | The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model |
title_sort | role of p19 and p21 h-ras proteins and mutants in mirna expression in cancer and a costello syndrome cell model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631104/ https://www.ncbi.nlm.nih.gov/pubmed/26138095 http://dx.doi.org/10.1186/s12881-015-0184-z |
work_keys_str_mv | AT garciacruzroseli theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT camatsmaria theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT calingeorgea theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT liuchanggong theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT voliniastefano theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT tacciolicristian theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT crocecarlom theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT bacheliasmontse theroleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT garciacruzroseli roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT camatsmaria roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT calingeorgea roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT liuchanggong roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT voliniastefano roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT tacciolicristian roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT crocecarlom roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel AT bacheliasmontse roleofp19andp21hrasproteinsandmutantsinmirnaexpressionincancerandacostellosyndromecellmodel |